Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients | Zendy

Ruth Maria Schorling | Zendy; Christian Pfrepper | Zendy; Thomas Golombek | Zendy; Chiara Alessandra Cella | Zendy; Nerea Muñoz-Unceta | Zendy; T. Siegemund | Zendy; Christoph Engel | Zendy; Sirak Petros | Zendy; Florian Lordick | Zendy; Maren Knödler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Biomarkers for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients

Author(s) -

Ruth Maria Schorling,

Christian Pfrepper,

Thomas Golombek,

Chiara Alessandra Cella,

Nerea Muñoz-Unceta,

T. Siegemund,

Christoph Engel,

Sirak Petros,

Florian Lordick,

Maren Knödler

Publication year - 2020

Publication title -

oncology research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.553

H-Index - 48

eISSN - 2296-5262

pISSN - 2296-5270

DOI - 10.1159/000508271

Subject(s) - medicine , ambulatory , cancer , gastroenterology , prospective cohort study , colorectal cancer , biomarker , d dimer , thrombosis , platelet activation , platelet , biochemistry , chemistry

Venous thromboembolism (VTE) is a common complication of cancer. This study aimed to evaluate immature platelet fraction (IPF), mean platelet volume (MPV), P-selectin, D-dimer, and thrombin generation (TG) as predictive biomarkers for VTE and further the improvement of existing risk assessment models (RAMs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research